{
    "eid": "2-s2.0-84993982880",
    "title": "Kinetics of serum HBsAg and intrahepatic cccDNA during pegylated interferon therapy in patients with HBeAg-positive and HBeAg-negative chronic hepatitis B",
    "cover-date": "2017-01-01",
    "subject-areas": [
        {
            "$": "Infectious Diseases",
            "@code": "2725"
        },
        {
            "$": "Virology",
            "@code": "2406"
        }
    ],
    "keywords": [
        "cccDNA",
        "HBsAg",
        "hepatitis B virus",
        "pegylated-interferon",
        "treatment response"
    ],
    "authors": [
        "Natthaya Chuaypen"
    ],
    "citedby-count": 35,
    "ref-count": 33,
    "ref-list": [
        "An algorithm for the grading of activity in chronic hepatitis C",
        "IFN-\u03b1 inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome",
        "Hepatitis B virus surface antigen levels: A guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B",
        "Serum Hepatitis B Surface Antigen Quantitation Can Reflect Hepatitis B Virus in the Liver and Predict Treatment Response",
        "Serum hepatitis B core-related antigen as a treatment predictor of pegylated interferon in patients with HBeAg-positive chronic hepatitis B",
        "New insight in the pathobiology of hepatitis B virus infection",
        "Impact of peginterferon alpha-2b and entecavir hydrate combination therapy on persistent viral suppression in patients with chronic hepatitis B",
        "Management of hepatitis B: Summary of a clinical research workshop",
        "Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients",
        "Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B",
        "Relationship between serum hepatitis B virus DNA and surface antigen with covalently closed circular DNA in HBeAg-negative patients",
        "Attacking hepatitis B virus cccDNA \u2013 The holy grail to hepatitis B cure",
        "Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA",
        "Hepatitis B viral DNA decline at loss of HBeAg is mainly explained by reduced cccdna load - down-regulated transcription of PgRNA has limited impact",
        "Hepatitis B surface antigen: Relation to hepatitis B replication parameters in HBeAg-negative chronic hepatitis B",
        "Peginterferon Alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B",
        "HBsAg quantification: Useful for monitoring natural history and treatment outcome",
        "HBV cccDNA: Viral persistence reservoir and key obstacle for a cure of chronic hepatitis B",
        "Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes",
        "Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levels",
        "Prediction of Sustained Response to Peginterferon Alfa-2b for Hepatitis B e Antigen\u2013Positive Chronic Hepatitis B Using On-Treatment Hepatitis B Surface Antigen Decline",
        "Intrahepatic hepatitis B virus covalently closed circular DNA can be a predictor of sustained response to therapy",
        "HBcrAg predicts hepatocellular carcinoma development: An analysis using time-dependent receiver operating characteristics",
        "Intrahepatic response markers in chronic hepatitis B patients treated with peginterferon alpha-2a and adefovir",
        "A case-control study on sequence variations in the enhancer II/core promoter/precore and X genes of hepatitis B virus in patients with hepatocellular carcinoma",
        "AASLD guidelines for treatment of chronic hepatitis B",
        "Serum hepatitis B surface antigen and hepatitis B e antigen titers: Disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers",
        "Hepatitis B virus infection",
        "Reduction of hepatitis B surface antigen and covalently closed circular DNA by nucleos(t)ide analogues of different potency",
        "Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B",
        "HBsAg Seroclearance in Chronic Hepatitis B in Asian Patients: Replicative Level and Risk of Hepatocellular Carcinoma",
        "New insight on hepatitis B virus persistence from the study of intrahepatic viral cccDNA",
        "Kinetics of intrahepatic covalently closed circular DNA and serum hepatitis B surface antigen during antiviral therapy for chronic hepatitis B: Lessons from experimental and clinical studies"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "affilname": "Chulalongkorn University",
        "affiliation-country": "Thailand"
    },
    "funding": []
}